VTRS earnings analysis
What we found in VTRS's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Viatris reported a strong Q1 2026 performance with revenues of $3.51 billion, an 8% increase from the previous year, and EPS of $0.59, surpassing estimates by 16%. Key growth was driven by a significant 22% rise in the Greater China segment, although gross margin decreased to 33% due to higher costs. Management reaffirmed fiscal 2026 guidance amid ongoing restructuring efforts and cost challenges.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Q1 Revenue Up 8% Year-over-Year
- Total revenues reached $3.51 billion in Q1 2026, up from $3.25 billion in Q1 2025, an increase of $262.7 million.
- EPS Beats Expectations
- Reported EPS of $0.59 exceeded consensus estimates of $0.51, resulting in a 15.69% surprise.
- Strong Growth in Greater China Segment
- Sales in the Greater China region grew by 22% to $680.1 million, significantly contributing to overall revenue growth.
- Operating Cash Flow
- Operating cash flow was $388.3 million, although down from $535.5 million the previous year.
- Reaffirmed Full-Year Guidance
- Management confirmed revenue guidance of $14.45 billion to $14.95 billion for fiscal 2026.
- Adjusted Gross Margin Stable at 56%
- Adjusted gross margin remained stable at 56% for both Q1 2026 and Q1 2025.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Increased Cost Pressures
- Cost of sales rose to $2.36 billion in Q1 2026, impacting gross margin which fell to 33%.
- Litigation Settlements
- Viatris accrued $450.8 million for legal contingencies, which could impact financial performance.
- Restructuring Costs
- Continued restructuring efforts have led to significant operational costs, which were about $92.5 million in Q1 2026.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $0.59
- Gross margin
- 33%
- Segment
- Developed Markets: $2.02B
- Segment
- Greater China: $680.1M
- Segment
- JANZ: $273.4M
- Segment
- Emerging Markets: $535.4M
What they said about what is next.
Management reaffirmed their full-year guidance for revenue and adjusted EBITDA.
The filing reads better than the one before it.
What came before.
- 10-K · February 26, 2026
- Viatris reported 2025 total revenues of $14.30 billion and highlights execution on its strategy to reshape the business: pipeline progress (five positive Phase 3 readouts), targeted M&A (Aculys acquisition) and…
- 10-Q · May 8, 2025
- Viatris reported Q1 total revenues of $3,254.3 million, down from $3,663.4 million a year ago, with gross margin of 35.7% and a GAAP diluted loss per share of $(2.55). Results were driven by a $2,936.8 million…
- 10-Q · November 7, 2024
- Viatris reported Q3 (three months ended September 30, 2024) total revenues of $3,751.2 million and diluted EPS of $0.08. Revenue, gross profit and operating income all declined versus the prior-year quarter while the…
- 10-Q · August 8, 2024
- Viatris reported Q2 total revenues of $3,796.6 million (down from $3,918.6 million in Q2 2023) and swung to a net loss of $326.4 million (vs. net income $264.0 million in Q2 2023), producing diluted EPS of $(0.27) (vs.…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing VTRS makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever